Innovative, Small Molecule Drugs ...made in Germany!
Phenex Pharmaceuticals is a drug discovery and development company focused on small-molecule drug discovery with a special emphasis on the target class of nuclear receptors.
We aim to utilize our special know how & technology platform to develop novel innovative therapies i.e. for liver and gastrointestinal diseases, chronic inflammatory diseases and cancer – indications with a high unmet medical need and a significant market potential.
Beyond our proprietary drug discovery programs we have assembled a powerful platform for research on nuclear receptors. We offer these assets on a fee-for-service basis to the Life Science industry under our Discovery Services unit.
Latest News / Events
- Phenex Announces Milestone Payment from Gilead as FXR drug candidate GS-9674 Enters Phase 1 Study.